Diagnostic Accuracy of Presepsin for Early Diagnosis of Sepsis in Critically Ill Obstetrics Patients

Abstract Background: Sepsis is a significant maternal health issue; presepsin (sCD14-ST) has emerged as a novel biomarker for diagnosis of sepsis. Aim: The aim of this study was to evaluate the diagnostic accuracy of presepsin for prediction of sepsis in critically ill obstetric patients. Methods: A prospective observational study was conducted in the Obstetrics Intensive Care Unit (ICU), over 18-month duration, involving 156 critically ill obstetric patients. Biomarkers including presepsin, C-reactive protein (CRP), and total leukocyte count (TLC) were measured on day 1 and day 3 of ICU admission. Presepsin was measured in serum sample by enzyme-linked immunosorbent assay (ELISA) technique using ELISA kit. Results: 44.9% critically ill obstetrics patients developed sepsis in ICU. The most common comorbidity was acute kidney injury (AKI; 20.0%), and AKI was 28.5% in septic patients. Maternal death occurred in 17.9%, with a significantly higher mortality among those who had sepsis (32.9%) compared to those without sepsis (5.8%). Presepsin levels significantly increased from day 1 value of 260 pg/mL to day 3 value of 350 pg/ml, after the development of sepsis ( P day 1). Presepsin outperformed CRP and TLC in early sepsis detection. Conclusion: Presepsin is a reliable early marker for sepsis in critically ill obstetric patients, with better diagnostic accuracy than CRP and TLC. Its serial monitoring may offer valuable prognostic insight.